Post Marketing Surveillance On The Safety And Tolerability Of Sunitinib Malate (Sutent) For Filipino Patients
Status:
Terminated
Trial end date:
2010-04-01
Target enrollment:
Participant gender:
Summary
The primary purpose is to monitor the safety and tolerability and effectiveness of sunitinib
malate in the treatment of patients with metastatic renal cell carcinoma and gastrointestinal
stromal tumor among filipino patients in usual clinical practice setting.